Yanying Li, PhD

Postdoctoral Fellows

Alumni

Social Profile:

Research Interests

Molecular simulation for drug design
Drug delivery system design
Nanomaterials synthesis
NIR I/II fluorescence imaging
Supramolecular self-assembly

Selected Publications

  • A D-peptide ligand of neuropeptide Y receptor Y1 serves as nanocarrier traversing of the blood brain barrier and targets glioma [J]. Nano Today, 2022, 44, 101465. (IF = 20.722)
  • Pressure-induced amorphous zeolitic imidazole frameworks with reduced toxicity and 
    Increased tumor accumulation improves therapeutic efficacy In vivo. Bioactive Materials, 2021, 6, 740-748.(IF = 14.6)
  • Localized NIR-II laser mediated chemodynamic therapy of glioblastoma [J]. Nano Today, 2022, 43, 101435. (IF = 20.722)
  • Manganese-Zeolitic Imidazolate Frameworks-90 with High Blood Circulation Stability for MRI-Guided Tumor Therapy. Nano-Micro Letters, 2019, 11, 61. (IF = 16.42)
  • Metal-free organo-theranostic nanosystem with high nitroxide stability and loading for image-guided targeted tumor therapy. ACS Nano, 2021, 15(2), 3079-3097. (IF = 15.9)
  • A Hybrid OrganoNanotheranostic Platform of Superlative Biocompatibility for Near-Infrared-Triggered Fluorescence Imaging and Synergistically Enhanced Ablation of Tumors. Small, 2020, 16, 2002445. (IF = 13.3)
  • Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo, Biomaterials, 2019, 197,41-50. (IF = 12.5)
  • Mixed Metal Metal–Organic Frameworks Derived Carbon Supporting ZnFe2O4/C for High-Performance Magnetic particle Imaging, Nano Letters, 2021, 21, 2730−2737. (IF = 11.2)
  • TiO2-based Surface-Enhanced Raman Scattering bio-probe for efficient circulating tumor cell detection on microfilter[J]. Biosensors and Bioelectronics, 2022: 114305. (IF=10.62)
  • Electrochemical gradients driven 3D printing of nano-twinned copper structures by direct current dynamic meniscus confined electrodeposition. Applied Materials Today, 2021, 24, 101138. (IF = 10.04)
  • The Neuropeptide Y1 Receptor Ligand-Modified Cell Membrane Promotes Targeted Photodynamic Therapy of Zeolitic Imidazolate Frameworks for Breast Cancer [J]. The Journal of Physical Chemistry Letters, 2021, 12(46): 11280-11287. (IF = 10.1)

Education

  • 2013-2017: B.Sc., Materials Forming & Control Engineering, Qinghai University, China
  • 2017-2022: Ph.D. Materials Physics and Chemistry, University of Chinese Academy of Sciences, China

Professional Profile

2022-Now, Postdoctoral fellow, KAUST, Thuwal, Saudi Arabia

Scientific and Professional Membership

Biophysical Society of China (Member)

Awards

  • National Inspirational Scholarship in 2014,2015,2016
  • Excellent Student Cadre in 2018
  • Merit Student in 2018 and 2020
  • Outstanding Graduates in 2022

KAUST Affiliations

PSE - Physical and Engineering Division

Research Interests Keywords

Blood brain barrier Glioma Self-assembly Target